MindWalk Holdings (HYFT) Net Shares Issued and Repurchased (2021 - 2022)
MindWalk Holdings' (HYFT) quarterly Net Shares Issued and Repurchased came in at $417674.7 in Q2 2022, down 9.8% year-over-year from $463075.5 in Q2 2021, and down 9.8% quarter-over-quarter from $463075.5 in Q2 2021.
Analysis
MindWalk Holdings (HYFT) Net Shares Issued and Repurchased (2021 - 2022) Analysis & Trends
MindWalk Holdings (HYFT) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $417674.7 the latest figure, recorded in Q2 2022.
- On a quarterly basis, Net Shares Issued and Repurchased fell 9.8% year-over-year to $417674.7 in Q2 2022; TTM through Apr 2022 was $417674.7, a 9.8% decrease from a year earlier, with the FY2022 full-year figure at $421799.5, down 5.38% from the prior year.
- Net Shares Issued and Repurchased was $417674.7 for Q2 2022 at MindWalk Holdings, down from $463075.5 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $463075.5 in Q2 2021 and troughed at $417674.7 in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |